About
19.94USD+0.17 +0.86%
Closed • Updated at 22:04 GMT+00:00Market Cap$1.77B
Volume1.15M
Beta0.02
RSI42.29
Gross Margin95.99%
Syndax Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 21 2026
Syndax Announces Four Revuforj® (revumenib) Abstracts Accepted for ASCO 2026, Including an Oral Presentation of Post-Transplant Data
May 20 2026
Syndax Announces Participation in Upcoming Investor Conferences
May 12 2026
Syndax Highlights 12 Revuforj® (revumenib) Abstracts Accepted for EHA 2026, Advancing Leadership in Menin Inhibition
Apr 30 2026
Syndax Reports First Quarter 2026 Financial Results and Provides Business Update
Apr 24 2026
Syndax to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on April 30, 2026
Community Chat
Ask AI
Try asking
Google Übersetzer